Compare MNDY & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MNDY | BIO |
|---|---|---|
| Founded | 2012 | 1952 |
| Country | Israel | United States |
| Employees | N/A | 7450 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Laboratory Analytical Instruments |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 7.1B |
| IPO Year | 2021 | N/A |
| Metric | MNDY | BIO |
|---|---|---|
| Price | $75.14 | $268.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 25 | 4 |
| Target Price | $174.92 | ★ $358.50 |
| AVG Volume (30 Days) | ★ 2.0M | 248.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $20.70 | $2.51 |
| Revenue Next Year | $16.48 | $3.17 |
| P/E Ratio | $34.38 | ★ $9.72 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $68.68 | $211.43 |
| 52 Week High | $316.98 | $343.12 |
| Indicator | MNDY | BIO |
|---|---|---|
| Relative Strength Index (RSI) | 37.81 | 42.45 |
| Support Level | $68.80 | $266.71 |
| Resistance Level | $80.58 | $289.61 |
| Average True Range (ATR) | 3.76 | 7.77 |
| MACD | 1.84 | 0.36 |
| Stochastic Oscillator | 46.51 | 29.77 |
Monday.com is a work management platform allowing for increased collaboration and visibility across an organization. Delivered via a SaaS-based model, users can track progress across marketing and development initiatives, create and automate workflows, and manage IT approvals. Revenue is generated on a per-seat basis across several pricing tiers. As of fiscal 2024, the company had over 245,000 customers.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.